Therapeutic Targets in Airway Inflammation

Pathophysiology of airway inflammation in asthma, Paula J. Busse and William W. Busse; primary human lung cells in the evaluation of airway determination, Tannishia Goggans and Serpil C. Erzurum; airway pH homeostasis in asthma and other inflammatory lung diseases, John Hunt and Benjamin Gaston; monitoring of exhaled breath to assess airway inflammation in asthma, Peter J. Barnes; the modulatory effects of carbon monoxide on the inflammatory response, Francis Whalen, Augustine M.K. Choi, and Jigme M. Sethi; reactive nitrogen species and tyrosine nitration in airway inflammation, Albert van der Vliet, Jason P. Eiserich, Brian Morrissey, and Carroll E. Cross; S-nitrosothiols in lung inflammation, Harvey E. Marshall, Loretta G. Que, Jonathan S. Stamler and Benjamin Gaston; contribution of different nitric oxide synthase isoforms to allergen-induced airway hyperresponsiveness and inflammation - lessons from murine models, George T. DeSanctis and El-Bdaoui Haddad; molecular mechanisms of increased nitric oxide airway inflammation, Weiling Xu and Serpil C. Erzurum; regulation of nitric oxide synthesis by inducible nitric oxide synthase, Pawel Kolodziejski and N. Tony Eissa; novel strategies for selective inhibition of inducible nitric oxide synthase, John F. Parkinson; leukocyte recruitment in allergic pulmonary inflammation, Bruce S. Bochner; neutrophil emigration in the lungs, Claire M. Doerschuk; dendritic cells , A. Karolina Palucka and Jacques Banchereau; the roles of mast cells in airway hyper-reactivity, inflammation and remodelling and immunoregulation in asthma, John L. Faul and Stephen J. Galli; mast cells exocytosis in airway inflammation, Roberto Adachi, Rupesh Nigam, and Burton Dickey. (Part contents).